(Q48285765)

10 February 2018

title

Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. (English)

1 reference

10 February 2018

0 references

1 reference

ChEBI release 2020-05-28

Hauss-Wegrzyniak B

1

1 reference

10 February 2018

Willard LB

2

1 reference

10 February 2018

Del Soldato P

3

1 reference

10 February 2018

Pepeu G

4

1 reference

10 February 2018

Wenk GL

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

published in

Brain Research

1 reference

10 February 2018

volume

815

1 reference

10 February 2018

issue

1

1 reference

10 February 2018

page(s)

36-43

1 reference

10 February 2018

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Cytokines in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Cytotoxicity of microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Expression of inducible cyclooxygenase mRNA in the mouse brain after systemic administration of bacterial lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: a current appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Activation of the classical complement pathway in brain tissue of Alzheimer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Anti-inflammatory drugs and Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Glial cytokines in Alzheimer's disease: review and pathogenic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Alzheimer's disease and rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Clinical trial of indomethacin in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Inflammation and Alzheimer's disease pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Effects of flurbiprofen and flurbinitroxybutylester on prostaglandin endoperoxide synthases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Pathogenesis of NSAID gastropathy: are neutrophils the culprits?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901081-6

10.1016/S0006-8993(98)01081-6

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018